This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Bao Cai, PhD
Executive Director, Process Development at Sarepta Therapeutics
Speaker

Profile

Bao Cai is currently the head of RNA process development at Sarepta, responsible for both PMO and PPMO platform technology development. He has over 20 years’ experience in pharmaceutical industry, specifically in oligonucleotides and peptides, ranging from discover research, process design, development, and validation. He received his Ph. D in organic chemistry from Nankai University.

Agenda Sessions

  • Characterization and Control Strategy of PMO Stereochemistry

    11:40am